This announcement is a separate document:
华泰联合证券有限责任公司关于荣昌生物制药(烟台)股份有限公司调整2024-2025年度日常关联交易预计的核查意见
Huatai United Securities Co., Ltd.'s verification opinion on Rongchang Biopharmaceutical (Yantai) Co., Ltd.'s adjustment of the 2024-2025 daily related transaction forecast
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.